Publication:
Prostatic Carcinosarcoma

dc.contributor.authorsYusuf ŞENOĞLU;Kamil ÇAM;HAVVA ERDEM;Muhammet Ali KAYIKÇI;Ali TEKİN
dc.date.accessioned2022-04-04T14:57:44Z
dc.date.accessioned2026-01-11T16:01:45Z
dc.date.available2022-04-04T14:57:44Z
dc.date.issued2017
dc.description.abstractProstat karsinosarkomu, sarkomatöz ve karsinomatöz unsurlardan oluşan nadir bir malignitedir. Sıklıkla kötü prognozu olan çok agresif tümörlerdir. Bu olgu sunumunda, 3 yıl maksimum androjen blokajı alan prostat adenokarsinomu olgusunda prostat karsinosarkomu gelişen 78 yaşındaki bir erkek hasta sunuldu. Bu nadir görülen malignitenin klinik ve patolojik özelliklerini güncel bilgilerle tanımlamaya çalıştık
dc.description.abstractProstatic carcinosarcoma is a rare malignancy composed of sarcomatous and carcinomatous elements. Predominantly, they are very aggressive tumors with a poor prognosis. In this case report, a 78 year-old male patient with prostate adenocarcinoma developing prostatic carcinosarcoma after using androgen blockade for 3 years was presented. We tried to define the clinical and pathological features of this rare malignancy with current information.
dc.identifier.issn2147-2122;2147-2270
dc.identifier.urihttps://hdl.handle.net/11424/261058
dc.language.isoeng
dc.relation.ispartofÜroonkoloji Bülteni
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectOnkoloji
dc.subjectÜroloji ve Nefroloji
dc.titleProstatic Carcinosarcoma
dc.title.alternativeProstat Karsinosarkomu
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage69
oaire.citation.issue2
oaire.citation.startPage67
oaire.citation.titleÜroonkoloji Bülteni
oaire.citation.volume16

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
613.17 KB
Format:
Adobe Portable Document Format